MX2020007987A - Cepa lactobacillus plantarum kbl396 y uso de la misma. - Google Patents
Cepa lactobacillus plantarum kbl396 y uso de la misma.Info
- Publication number
- MX2020007987A MX2020007987A MX2020007987A MX2020007987A MX2020007987A MX 2020007987 A MX2020007987 A MX 2020007987A MX 2020007987 A MX2020007987 A MX 2020007987A MX 2020007987 A MX2020007987 A MX 2020007987A MX 2020007987 A MX2020007987 A MX 2020007987A
- Authority
- MX
- Mexico
- Prior art keywords
- strain
- lactobacillus plantarum
- alleviation
- kbl396
- disorders
- Prior art date
Links
- 240000006024 Lactobacillus plantarum Species 0.000 title abstract 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title abstract 2
- 229940072205 lactobacillus plantarum Drugs 0.000 title abstract 2
- 208000012902 Nervous system disease Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 239000006166 lysate Substances 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Physics & Mathematics (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
Abstract
La presente invención se relaciona a una cepa de bacterias de ácido láctico novedosa, Lactobacillus plantarum KBL396 (KCTC13279SP), una composición que comprende por lo menos una seleccionada del grupo que consiste de un cultivo de la cepa, un lisado de la cepa y un extracto de la cepa, y un uso de la misma en alimentos y fármacos. Una cepa y una composición de acuerdo con la presente invención exhiben excelentes efectos en el alivio de trastornos neurológicos, especialmente trastornos mentales y trastornos neurodegenerativos, y no tiene riesgos de efectos secundarios en un cuerpo humano, y para de esta manera encontrar aplicación útil en el alivio de trastornos neurológicos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20180013366 | 2018-02-02 | ||
PCT/KR2019/001525 WO2019151843A1 (ko) | 2018-02-02 | 2019-02-07 | 락토바실러스 플란타럼 kbl396 균주 및 그 용도 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020007987A true MX2020007987A (es) | 2020-09-09 |
Family
ID=67479352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020007987A MX2020007987A (es) | 2018-02-02 | 2019-02-07 | Cepa lactobacillus plantarum kbl396 y uso de la misma. |
Country Status (11)
Country | Link |
---|---|
US (1) | US11602552B2 (es) |
EP (1) | EP3747988A4 (es) |
JP (1) | JP6994116B2 (es) |
KR (1) | KR102265538B1 (es) |
CN (1) | CN112204129B (es) |
AU (1) | AU2019216129B2 (es) |
BR (1) | BR112020015599A2 (es) |
CA (1) | CA3089187A1 (es) |
MX (1) | MX2020007987A (es) |
RU (1) | RU2764639C1 (es) |
WO (1) | WO2019151843A1 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102249260B1 (ko) * | 2019-10-10 | 2021-05-10 | 경희대학교 산학협력단 | 신규 유산균 및 이의 용도 |
GB201915144D0 (en) * | 2019-10-18 | 2019-12-04 | Multigerm Uk Entpr Ltd | Method of promoting SCFA production by gut microbiota |
CN110684694A (zh) * | 2019-11-05 | 2020-01-14 | 北京科拓恒通生物技术股份有限公司 | 一株缓减精神紧张的植物乳杆菌及其应用 |
CA3159798A1 (en) * | 2019-11-08 | 2021-05-14 | Biogaia Ab | Serotonin producing bacteria |
KR102274678B1 (ko) * | 2020-07-16 | 2021-07-12 | (주)코엔바이오 | 신규한 락토바실러스 플란타룸 아종 플란타룸 Ceb-kc-007 균주 및 이를 포함하는 항비만 효능을 가지는 조성물 |
KR102501177B1 (ko) * | 2020-09-16 | 2023-02-16 | 한국생명공학연구원 | 신규한 락토바실러스 플란타럼 균주 및 이를 이용한 패오니플로린의 생물전환방법 |
EP4265297A1 (en) * | 2020-12-16 | 2023-10-25 | Meiji Co., Ltd | Composition for improving inflammation of brain tissue |
CN112915109B (zh) * | 2021-01-21 | 2023-03-24 | 吉林省农业科学院 | 植物乳杆菌dp189在制备预防和/或治疗阿尔茨海默病药物中的应用 |
CN113073066B (zh) * | 2021-04-16 | 2022-01-04 | 段云峰 | 罗伊氏乳杆菌及其应用、组合物、药物和食品 |
KR102425902B1 (ko) * | 2021-06-15 | 2022-07-28 | 농업회사법인 유한회사 영인바이오 | 반려동물용 라면 및 이의 제조방법 |
CN113698503B (zh) * | 2021-08-16 | 2022-05-24 | 华南理工大学 | 一种植物乳杆菌中性胞外多糖及其应用 |
TWI810645B (zh) * | 2021-09-06 | 2023-08-01 | 景岳生物科技股份有限公司 | 乳桿菌組合物及其改善抗生素造成之焦慮症的用途 |
KR102661505B1 (ko) * | 2021-09-17 | 2024-05-07 | 주식회사 평강비아이엠 | 고염도 어류 폐기물을 이용한 사료제조방법 |
KR20230077692A (ko) | 2021-11-25 | 2023-06-01 | 국민대학교산학협력단 | 바실러스 벨레젠시스 생산 대사산물 및 락토바실러스 플란타럼 생산 대사산물을 혼합한 혼합 대사산물을 유효성분으로 포함하는 퇴행성 뇌질환 예방 또는 치료용 약학 조성물 |
US20230414685A1 (en) * | 2022-05-26 | 2023-12-28 | Pouda Biotech Llc | Lactobacillus plantarum pda6 having neurological effects and compositions including the same |
KR20240023749A (ko) | 2022-08-16 | 2024-02-23 | 주식회사 휴럼 | 락티플란티실러스 플란타룸 hmap12 균주 및 이를 포함하는 미세먼지에 의한 기관지염의 예방 또는 개선용 건강기능성 식품 조성물 |
KR102540559B1 (ko) | 2023-03-09 | 2023-06-13 | 주식회사 락토메이슨 | 락토바실러스 아시도필루스 lm1060 균주를 유효성분으로 포함하는 인지능력 개선용 조성물 및 이의 용도 |
CN117327631B (zh) * | 2023-11-29 | 2024-01-26 | 山东环亿生物科技有限公司 | 一种改善焦虑抑郁植物乳杆菌株10a-2及其用途 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0700552A2 (en) * | 2007-08-27 | 2009-03-30 | Janos Dr Feher | Method and composition inhibiting inflammation |
CN101302488B (zh) * | 2008-07-04 | 2010-06-30 | 中国科学院微生物研究所 | 一种生产乳酸的方法及其专用植物乳杆菌 |
BRPI0921617A2 (pt) | 2008-11-03 | 2015-08-18 | Nestec Sa | Composicao nutricional compreendendo probioticos e padroes do sono aperfeicoados |
BR112012018813B1 (pt) | 2010-01-28 | 2020-12-08 | Ab-Biotics S.A. | composição compreendendo cepas bacterianas com atividade anti-inflamatória, imunomoduladora, antiibs ou antidistensão abdominal, uso das mesmas, bem como produtos farmacêutico, veterinário e comestível compreendendo a referida composição |
JP5923238B2 (ja) | 2010-07-07 | 2016-05-24 | アサヒグループホールディングス株式会社 | 迷走神経活性化剤 |
KR101394348B1 (ko) * | 2011-10-28 | 2014-05-13 | 대상에프앤에프 주식회사 | 대사질환 또는 염증질환 치료 및 예방 효과가 있는 락토바실러스 플란타륨 dsr920 및 이의 용도 |
CA3208225A1 (en) * | 2012-01-16 | 2013-07-25 | Elizabeth Mckenna | Compositions and methods for the treatment of hepatitic diseases and disorders |
CN117064923A (zh) * | 2013-04-03 | 2023-11-17 | 普罗比公司 | 益生菌菌株用于治疗或预防骨质疏松 |
ES2624673T3 (es) | 2014-04-23 | 2017-07-17 | National Yang-Ming University | Bacteria ácido láctica, composición que la contiene y su uso |
KR101620163B1 (ko) | 2014-05-23 | 2016-05-12 | 인제대학교 산학협력단 | 미강 추출물을 유효성분으로 포함하는 우울증 또는 인지장애의 예방 또는 치료용 조성물 |
ES2929100T3 (es) * | 2014-10-28 | 2022-11-24 | Medlab Ip Pty Ltd | Tratamiento para la depresión y los trastornos depresivos |
JP6898628B2 (ja) * | 2016-06-15 | 2021-07-07 | 国立大学法人広島大学 | 神経変性疾患治療剤 |
US11285179B2 (en) | 2016-07-19 | 2022-03-29 | Bened Biomedical Co., Ltd. | Method for preventing or treating movement disorders with lactic acid bacterium |
MY184908A (en) * | 2018-09-03 | 2021-04-30 | Aqurate Ingredients Intl M Sdn Bhd | Use of a probiotic metabolite for slowing signs of aging |
TWI731279B (zh) * | 2018-11-21 | 2021-06-21 | 葡萄王生技股份有限公司 | 發酵乳桿菌gkf3、含其之組合物及改善精神失調之用途 |
WO2020171256A1 (ko) | 2019-02-21 | 2020-08-27 | 서울대학교산학협력단 | 클로스트리디움 디피실레(clostridium difficile) 성장 억제효과를 갖는 락토바실러스 균주 |
CA3159798A1 (en) * | 2019-11-08 | 2021-05-14 | Biogaia Ab | Serotonin producing bacteria |
CN112915109B (zh) * | 2021-01-21 | 2023-03-24 | 吉林省农业科学院 | 植物乳杆菌dp189在制备预防和/或治疗阿尔茨海默病药物中的应用 |
-
2019
- 2019-02-07 US US16/962,976 patent/US11602552B2/en active Active
- 2019-02-07 MX MX2020007987A patent/MX2020007987A/es unknown
- 2019-02-07 JP JP2020541769A patent/JP6994116B2/ja active Active
- 2019-02-07 AU AU2019216129A patent/AU2019216129B2/en active Active
- 2019-02-07 RU RU2020126110A patent/RU2764639C1/ru active
- 2019-02-07 WO PCT/KR2019/001525 patent/WO2019151843A1/ko unknown
- 2019-02-07 EP EP19747730.0A patent/EP3747988A4/en active Pending
- 2019-02-07 CN CN201980011169.8A patent/CN112204129B/zh active Active
- 2019-02-07 BR BR112020015599-3A patent/BR112020015599A2/pt unknown
- 2019-02-07 CA CA3089187A patent/CA3089187A1/en active Pending
- 2019-02-07 KR KR1020190014501A patent/KR102265538B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN112204129A (zh) | 2021-01-08 |
EP3747988A4 (en) | 2021-11-03 |
RU2764639C1 (ru) | 2022-01-19 |
EP3747988A1 (en) | 2020-12-09 |
JP6994116B2 (ja) | 2022-02-04 |
KR20190094125A (ko) | 2019-08-12 |
CA3089187A1 (en) | 2019-08-08 |
US11602552B2 (en) | 2023-03-14 |
AU2019216129B2 (en) | 2022-03-17 |
WO2019151843A1 (ko) | 2019-08-08 |
CN112204129B (zh) | 2023-12-15 |
AU2019216129A1 (en) | 2020-08-06 |
US20220040243A1 (en) | 2022-02-10 |
JP2021511804A (ja) | 2021-05-13 |
KR102265538B1 (ko) | 2021-06-16 |
BR112020015599A2 (pt) | 2021-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020007987A (es) | Cepa lactobacillus plantarum kbl396 y uso de la misma. | |
NZ630117A (en) | Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same | |
WO2016086210A8 (en) | Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease | |
EP4257194A3 (en) | Use of microbial communities for human and animal health | |
EP3584308A3 (en) | Compositions and methods | |
PH12019502725A1 (en) | Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety | |
WO2018229236A3 (en) | COMPOSITIONS COMPRISING BACTERIAL STRAINS | |
WO2019066599A3 (ko) | 신규 유산균 및 이의 용도 | |
MY181102A (en) | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | |
WO2015112980A3 (en) | Dermaseptin-type and piscidin-type antimicrobial peptides | |
IL291445A (en) | Bacterial strains, their compositions and their use in the treatment of gastrointestinal disorders | |
WO2018231992A3 (en) | METHODS OF USING LACTOBACILLUS PLANTARUM STRAINS TO PROTECT ANIMALS AGAINST PATHOGENIC BACTERIAL INFECTION | |
PH12018550110A1 (en) | Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation | |
WO2020008149A8 (fr) | Utilisation d'une souche de roseburia intestinalis pour la prévention et le traitement de l'inflammation de l'intestin | |
WO2017199022A3 (en) | Lactobacillus rhamnosus lysate compositions and uses thereof | |
WO2019098810A3 (ko) | 신규 유산균 및 이의 용도 | |
PH12017502042A1 (en) | Dietary supplement | |
MX2017007654A (es) | Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas. | |
WO2015121458A3 (fr) | Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149 | |
WO2021004958A3 (en) | Compositions comprising bacterial strains | |
WO2018004224A3 (ko) | 신규 스포리치아과 미생물 및 그의 용도 | |
AU2018225957A1 (en) | Composition for alleviating mental health disorder | |
EP3757207A4 (en) | Bifidobacterium lungum rapo strain for alleviation, prevention, or treatment of rheumatoid arthritis and composition comprising same | |
WO2020091180A3 (ko) | 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물 | |
MX2020001632A (es) | Composiciones que comprenden cepas bacterianas. |